In Vivo Longitudinal and Multimodal Imaging of Hypoxia-Inducible Factor 1α and Angiogenesis in Breast Cancer

0
0
0

In Vivo Longitudinal and Multimodal Imaging of Hypoxia-Inducible Factor 1α and Angiogenesis in Breast Cancer

Breast cancer remains a leading cause of cancer-related mortality worldwide, with tumor angiogenesis and hypoxia playing pivotal roles in disease progression and therapeutic resistance. Hypoxia-inducible factor 1α (HIF-1α), a master regulator of cellular adaptation to low oxygen conditions, drives angiogenesis by activating genes that promote neovascularization. This study establishes a novel murine allograft model for longitudinal, non-invasive assessment of HIF-1α activity and angiogenesis during breast cancer growth using fluorescence imaging (FLI) and contrast-enhanced ultrasound (CEUS). The integration of molecular and functional imaging modalities provides dynamic insights into tumor microenvironmental changes, offering a platform for evaluating anti-angiogenic therapies.

Establishment of the HIF-1α Reporter Cell Line

The study utilized the murine breast cancer cell line Ca761, which was stably transfected with a hypoxia-responsive 5HRE/GFP plasmid. This construct contains five copies of the hypoxia-responsive element (HRE) from the human vascular endothelial growth factor (VEGF) promoter, driving the expression of destabilized enhanced green fluorescent protein (GFP) under hypoxic conditions. Transfection was performed using Lipofectamine 2000, followed by selection of monoclonal cell populations. Cells were validated under cobalt chloride (CoCl₂)-simulated hypoxia, a chemical inducer that stabilizes HIF-1α by inhibiting prolyl hydroxylase activity.

Under normoxia, Ca761-hre-gfp cells showed no GFP fluorescence. However, treatment with 200 μmol/L CoCl₂ for 16 hours induced robust GFP expression, visualized via fluorescence microscopy. Western blotting confirmed HIF-1α stabilization, with protein levels increasing dose-dependently in response to CoCl₂ (100 μmol/L and 200 μmol/L). These in vitro experiments confirmed the cell line’s ability to report HIF-1α activity dynamically.

In Vivo Tumor Model and Imaging Protocol

Subcutaneous allografts were established in twelve 6-week-old female 615 mice by injecting 2×10⁷ Ca761-hre-gfp cells into the left rear flank. Tumor growth was monitored longitudinally at four time points: days 4, 9, 15, and 19 post-inoculation. At each interval, three mice were sacrificed for histopathological correlation, while the remaining underwent multimodal imaging:

  1. Fluorescence Imaging (FLI):
    HIF-1α activity was quantified using a NightOWL II LB 983 system with 470 nm excitation and 500 nm emission filters. Regions of interest (ROIs) were drawn around tumors, and photon counts (ph/s) were measured. FLI signals increased from 1.02 ± 0.82 ph/s on day 4 to a peak of 4.01 ± 0.57 ph/s on day 15, followed by a decline to 2.11 ± 1.09 ph/s by day 19 (P = 0.024). This biphasic trend suggested early hypoxia induction followed by reduced HIF-1α activity in later stages.

  2. Contrast-Enhanced Ultrasound (CEUS):
    Tumor perfusion was assessed using a Philips iU22 scanner with SonoVue microbubbles. CEUS peak intensity, reflecting blood flow, increased from 55.60 ± 2.43 on day 4 to 70.57 ± 5.51 on day 15, then decreased to 55.7 ± 6.81 on day 19 (P = 0.020). Three enhancement patterns were observed:

    • Type I (Days 4–9): Homogeneous concentric enhancement, indicating uniform vascularization.
    • Type II (Day 15): Heterogeneous enhancement with hypoechoic regions, suggesting central necrosis.
    • Type III (Day 19): Rim-like enhancement, characterized by peripheral hypervascularity and avascular cores.

Histopathological Correlation

Immunohistochemistry (IHC) for HIF-1α and CD34 (microvessel marker) validated imaging findings:

  • HIF-1α Expression: Staining intensity (graded 0–3) peaked on day 15 (grade 2.7 ± 0.5), correlating with FLI photon counts (r = 0.769, P = 0.003). Nuclear and cytoplasmic localization confirmed hypoxia-driven transcriptional activity.
  • Microvessel Density (MVD): CD34-positive vessels decreased from 49.7 ± 7.5 vessels/field on day 4 to 36.6 ± 1.7 on day 15, rebounding to 44.1 ± 5.5 on day 19 (P = 0.040). Despite this, CEUS peak intensity did not correlate with MVD (r = −0.430, P = 0.215), highlighting discrepancies between structural vascular density and functional perfusion.

Mechanistic Insights and Clinical Implications

The biphasic HIF-1α activity pattern aligns with prior studies showing initial hypoxia induction followed by feedback downregulation under chronic hypoxia. CEUS revealed a shift from diffuse to peripheral angiogenesis, a hallmark of aggressive tumors. The rim-like enhancement (Type III) mirrors clinical observations in malignant breast lesions, underscoring CEUS’s diagnostic potential.

FLI’s ability to track HIF-1α dynamics non-invasively offers a tool for evaluating anti-HIF therapies. However, limitations include tissue autofluorescence in the green spectrum and shallow penetration depth, restricting FLI to preclinical applications.

Strengths and Innovations

This study introduces a dual-modality imaging platform combining FLI and CEUS to dissect hypoxia and angiogenesis interdependencies. The Ca761-hre-gfp model enables real-time monitoring of therapeutic responses, particularly for HIF-1α inhibitors. The use of immunocompetent 615 mice enhances translational relevance compared to xenograft models.

Limitations and Future Directions

The study’s four time points provide limited temporal resolution. Future work could incorporate more intervals and therapeutic interventions. Additionally, advanced FLI probes with near-infrared emission could mitigate autofluorescence issues.

Conclusion

The Ca761-hre-gfp allograft model successfully integrates molecular and functional imaging to map HIF-1α activity and angiogenesis during breast cancer progression. This platform holds promise for preclinical drug evaluation and mechanistic studies of tumor microenvironmental adaptation.

doi.org/10.1097/CM9.0000000000000616

Was this helpful?

0 / 0